ARIPIPRAZOLE VERSUS HALOPERIDOL TREATMENT IN EARLY-STAGE SCHIZOPHRENIA

We conducted a secondary analysis of a completed study of the differential efficacy and side effects of aripiprazole versus haloperidol in early-stage schizophrenia (ESS), a subpopulation of patients which does not include first episode or chronic patients. A subpopulation of 360 individuals with ES...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Psychiatr Res
Hlavní autoři: Girgis, Ragy R., Merrill, David B., Vorel, Stanislav R., Kim, Edward, Portland, Kimberly, You, Min, Pikalov, Andrei, Whitehead, Richard, Lieberman, Jeffrey A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4456013/
https://ncbi.nlm.nih.gov/pubmed/20937506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2010.09.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky